Found 0 matching trials
Therapy Optimization in Multiple Sclerosis (MS)
N/AThe purpose of this study is to determine if higher compliance and adherenc...
Location
Teva Investigational Site
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
NAFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis
PHASE2The purpose of this study is to determine if natalizumab in combination wit...
Location
Multiple Locations
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
PHASE4The primary objective of the study is to assess the clinical efficacy of Re...
Location
University of Alabama at Birmingham
Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
PHASE2Teva is developing 40 mg/ml Glatiramer Acetate (GA) Injection , administere...
The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections
PHASE4Participants with multiple sclerosis that are currently treated with glatir...
Location
Multiple Locations
Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients
PHASE3This is an open-label, multicenter study conducted at approximately 20 site...
Location
Multiple Locations
Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
PHASE3This was a multicenter, randomized, open-label, parallel-group, active-cont...
Safety and Tolerability of Glatiramer Acetate
PHASE3This is an open-label, randomized, multi-center, parallel-arm study to asse...
Location
Teva Investigational Site 10706
Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications
PHASE4The purpose of this study is to see if applying an anesthetic topical adhes...
Location
MS Center at Evergreen Health